Discrepancies in Written Versus Calculated Durations in Opioid Prescriptions: Pre-Post Study

por Slovis, Benjamin H, Kairys, John, Babula, Bracken, Girondo, Melanie, Martino, Cara, Roke, Lindsey M, Riggio, Jeffrey
Publicado 2020

Reduction in Hospital System Opioid Prescribing for Acute Pain Through Default Prescription Preference Settings: Pre–Post Study

por Slovis, Benjamin Heritier, Riggio, Jeffrey M, Girondo, Melanie, Martino, Cara, Babula, Bracken, Roke, Lindsey M, Kairys, John C
Publicado 2021

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms

por Peck, Amy R, Girondo, Melanie A, Liu, Chengbao, Kovatich, Albert J, Hooke, Jeffrey A, Shriver, Craig D, Hu, Hai, Mitchell, Edith P, Freydin, Boris, Hyslop, Terry, Chervoneva, Inna, Rui, Hallgeir
Publicado 2016

Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment

por Yang, Ning, Liu, Chengbao, Peck, Amy R, Girondo, Melanie A, Yanac, Alicia F, Tran, Thai H, Utama, Fransiscus E, Tanaka, Takemi, Freydin, Boris, Chervoneva, Inna, Hyslop, Terry, Kovatich, Albert J, Hooke, Jeffrey A, Shriver, Craig D, Rui, Hallgeir
Publicado 2013

Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression

por Sato, Takahiro, Tran, Thai H., Peck, Amy R., Girondo, Melanie A., Liu, Chengbao, Goodman, Chelain R., Neilson, Lynn M., Freydin, Boris, Chervoneva, Inna, Hyslop, Terry, Kovatich, Albert J., Hooke, Jeffrey A., Shriver, Craig D., Fuchs, Serge Y., Rui, Hallgeir
Publicado 2013

Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury

por Bhattacharya, Sabyasachi, Katlinski, Kanstantsin V, Reichert, Maximilian, Takano, Shigetsugu, Brice, Angela, Zhao, Bin, Yu, Qiujing, Zheng, Hui, Carbone, Christopher J, Katlinskaya, Yuliya V, Leu, N Adrian, McCorkell, Kelly A, Srinivasan, Satish, Girondo, Melanie, Rui, Hallgeir, May, Michael J, Avadhani, Narayan G, Rustgi, Anil K, Fuchs, Serge Y
Publicado 2014

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes

por Peck, Amy R, Witkiewicz, Agnieszka K, Liu, Chengbao, Klimowicz, Alexander C, Stringer, Ginger A, Pequignot, Edward, Freydin, Boris, Yang, Ning, Ertel, Adam, Tran, Thai H, Girondo, Melanie A, Rosenberg, Anne L, Hooke, Jeffrey A, Kovatich, Albert J, Shriver, Craig D, Rimm, David L, Magliocco, Anthony M, Hyslop, Terry, Rui, Hallgeir
Publicado 2012

High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer

por Chervoneva, Inna, Peck, Amy R., Sun, Yunguang, Yi, Misung, Udhane, Sameer S., Langenheim, John F., Girondo, Melanie A., Jorns, Julie M., Chaudhary, Lubna N., Kamaraju, Sailaja, Bergom, Carmen, Flister, Michael J., Hooke, Jeffrey A., Kovatich, Albert J., Shriver, Craig D., Hu, Hai, Palazzo, Juan P., Bibbo, Marluce, Hyslop, Terry, Nevalainen, Marja T., Pestell, Richard G., Fuchs, Serge Y., Mitchell, Edith P., Rui, Hallgeir
Publicado 2023